EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation

Mariya Timotey Miteva, Davide Laurenti, Roberto Mattioli, Daniel Di Risola, Alessia Mariano, Luciana Mosca

Frontiers in Nutrition · 13.02.2026 · 13

DOI: 10.3389/fnut.2026.1676497 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 13.02.2026. Verfasst von Mariya Timotey Miteva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Pharmacology, CNR, Rome, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ateneo 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by beta-amyloid (Aβ) deposition, hyperphosphorylation of tau protein (pTau), mitochondrial impairment and neuroinflammation. Several risk factors, such as aging, genetics, cardiovascular diseases (CVD) and lifestyle, concur to the onset of the disease. Among modifiable risk factors, micronutrient intake has gained attention for its potential role in preventing or slowing down disease progression. In this narrative review, we summarize current evidence linking vitamin deficiencies to the onset and progression of AD. We analyze evidence for fat-soluble (A, D, E, K) and water-soluble vitamins (C and B-complex, both canonical B1–B12 and non-canonical forms such as B13, B15, and B17). We then analyze individual and combinational vitamin supplementation in AD patients as the primary focus, with additional data derived from animal and cellular studies when human data are limited. As final result, B6, B9, and B12 vitamins have demonstrated promising effects in clinical trials. Interestingly, some beneficial effects have also been observed in the prodromal stage of AD when these vitamins were combined with antioxidant compounds such as vitamin C and vitamin E. Given the multifactorial nature of AD, targeting isolated vitamin deficiencies may not be sufficient. Future research should focus on long-term clinical trials (at least 2 years), particularly exploring combinations of vitamins and antioxidants, to achieve meaningful therapeutic effects. This review is intended as a point of support for future clinical trials in the treatment of AD from a nutritional point of view.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseasehypovitaminosisneurodegenerationnutritionoxidative stressvitamin cocktailvitamin supplementationvitamins

Autor:innen und Institutionen

  • Institute of Translational Pharmacology, CNR, Rome, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
  • Department of Biochemical Sciences, Faculty of Pharmacy and Medicine, Sapienza University, Rome, Italy.

Förderung

  • Ateneo 2023

Zitieren

APA

Miteva, M. T., Laurenti, D., Mattioli, R., Di Risola, D., Mariano, A., & Mosca, L. (2026). Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1676497

Vancouver

Miteva MT, Laurenti D, Mattioli R, Di Risola D, Mariano A, Mosca L. Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1676497

BibTeX
@article{Miteva2026,
  author = {Miteva, Mariya Timotey and Laurenti, Davide and Mattioli, Roberto and Di Risola, Daniel and Mariano, Alessia and Mosca, Luciana},
  title = {Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1676497}
}
Kostenlos starten →